Skip to content

Governments investing in new vaccine-manufacturing plant in Toronto

TORONTO — The governments of Canada and Ontario are investing in a new influenza vaccine manufacturing facility in Toronto, sources tell The Canadian Press.
National News

TORONTO — The governments of Canada and Ontario are investing in a new influenza vaccine manufacturing facility in Toronto, sources tell The Canadian Press.

Sources say the federal government will invest $415 million in the partnership with Sanofi Pasteur Ltd.

Ontario's government will contribute $55 million to the project, according to the sources.

Sanofi will invest more than $455 million as well as create and maintain 1,225 highly skilled jobs in Canada.

The company will also invest at least $79 million a year to fund Canadian research and development.

This new facility will ensure drug product formulation, fill-and-finish and inspection of flu vaccines.

This report by The Canadian Press was first published March 31, 2021.

The Canadian Press

push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks